Pharmalex Belgium

Pharmalex Belgium is a company in Mont Saint Guibert, Belgium that has taken part in 2 EU-funded projects since 2017, receiving €539k in EU funding.

EU funding received€539k
EU projects2
As coordinator0
Running now1
First EU project2017
Latest project2021
CountryBelgium
EU registration (PIC)905108650
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Pharmalex Belgium's own share of each project, not the project's full budget.

  • Horizon 2020€539k · 2 projects

Projects

2 EU-funded projects, newest first. Each links to the official record.

  • Inno4VacPartner

    Innovations to accelerate vaccine development and manufacture

    Horizon 2020 · 2021–2028 · Project on CORDIS ↗

    €470ktheir share
  • EQIPDPartner

    European Quality In Preclinical Data

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €69ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • alzheimer
  • big data
  • data science
  • governance
  • immunology
  • influenza
  • machine learning
  • mathematical model
  • neurobiology
  • vaccines

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime